Netflix, Inc. (NFLX)

Verve Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	41,693	39,001	33,723	31,616	29,698	24,996
Revenue Growth (YoY)	14.84%	15.65%	6.67%	6.46%	18.81%	24.01%
Cost of Revenue	21,476	21,038	19,715	19,168	17,333	15,276
Gross Profit	20,217	17,963	14,008	12,447	12,365	9,720
Selling, General & Admin	4,754	4,620	4,378	4,103	3,897	3,305
Research & Development	3,159	2,925	2,676	2,711	2,274	1,830
Operating Expenses	7,914	7,545	7,054	6,814	6,171	5,134
Operating Income	12,304	10,418	6,954	5,633	6,195	4,585
Interest Expense	-744.25	-718.73	-699.83	-706.21	-765.62	-767.5
Interest & Investment Income	318	294	281	60	8.21	41.56
Currency Exchange Gain (Loss)	-205	-18	-293	282	403	-660
Other Non Operating Income (Expenses)	9.94	-9.22	-36.77	-4.69	-	-
Pretax Income	11,683	9,966	6,205	5,264	5,840	3,199
Income Tax Expense	1,435	1,254	797.42	772.01	723.88	437.95
Net Income	10,248	8,712	5,408	4,492	5,116	2,761
Net Income to Common	10,248	8,712	5,408	4,492	5,116	2,761
Net Income Growth	44.44%	61.09%	20.39%	-12.20%	85.28%	47.91%
Shares Outstanding (Basic)	427	430	442	445	443	441
Shares Outstanding (Diluted)	437	439	449	451	455	454
Shares Change (YoY)	-1.57%	-2.28%	-0.40%	-0.90%	0.26%	0.54%
EPS (Basic)	23.99	20.28	12.25	10.10	11.55	6.26
EPS (Diluted)	23.46	19.83	12.03	9.95	11.24	6.08
EPS Growth	46.83%	64.84%	20.91%	-11.48%	84.87%	47.22%
Free Cash Flow	8,501	6,922	6,926	1,619	-131.98	1,929
Free Cash Flow Per Share	19.46	15.76	15.41	3.59	-0.29	4.25
Gross Margin	48.49%	46.06%	41.54%	39.37%	41.64%	38.88%
Operating Margin	29.51%	26.71%	20.62%	17.82%	20.86%	18.34%
Profit Margin	24.58%	22.34%	16.04%	14.21%	17.23%	11.05%
Free Cash Flow Margin	20.39%	17.75%	20.54%	5.12%	-0.44%	7.72%
EBITDA	12,624	10,747	7,311	5,970	6,403	4,701
EBITDA Margin	30.28%	27.56%	21.68%	18.88%	21.56%	18.81%
D&A For EBITDA	320.53	328.91	356.95	336.68	208.41	115.71
EBIT	12,304	10,418	6,954	5,633	6,195	4,585
EBIT Margin	29.51%	26.71%	20.62%	17.82%	20.86%	18.34%
Effective Tax Rate	12.28%	12.58%	12.85%	14.67%	12.39%	13.69%
Advertising Expenses	-	1,779	1,732	1,586	1,669	1,447

Updated Jul 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q